| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 86 |
| 1 | LETROZOLE | 78 |
| 2 | FULVESTRANT | 62 |
| 3 | LETROZOLE TABLETS | 60 |
| 4 | ANASTROZOLE | 53 |
| 5 | EXEMESTANE | 41 |
| 6 | ANASTROZOLE TABLETS | 40 |
| 7 | OCTREOTIDE ACETATE | 40 |
| 8 | BEVACIZUMAB | 38 |
| 9 | CARBOPLATIN | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 1 | CEFOTETAN | 1 | 0.0075 |
| 2 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 4 | 0.0039 |
| 3 | RIBOCICLIB | 86 | 0.0026 |
| 4 | CABAZITAXEL | 9 | 0.0026 |
| 5 | GOSERELIN | 34 | 0.0025 |
| 6 | EXEMESTANE | 41 | 0.0019 |
| 7 | FULVESTRANT | 62 | 0.0019 |
| 8 | ANASTROZOLE TABLETS | 40 | 0.0018 |
| 9 | SORBITOL | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 132 |
| 1 | Kinase Inhibitor [EPC] | 89 |
| 2 | Platinum-based Drug [EPC] | 71 |
| 3 | Estrogen Receptor Antagonist [EPC] | 64 |
| 4 | Microtubule Inhibitor [EPC] | 55 |
| 5 | Corticosteroid [EPC] | 53 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 49 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 38 |
| 9 | Benzodiazepine [EPC] | 36 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 64 | 0.0016 |
| 1 | Aromatase Inhibitor [EPC] | 132 | 0.0012 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 3 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 4 | Somatostatin Analog [EPC] | 6 | 0.0009 |
| 5 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 14 | 0.0007 |
| 7 | Radioligand Therapeutic Agent [EPC] | 7 | 0.0005 |
| 8 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 18 | 0.0004 |